Do GLP-1 Supplements Work? What the Evidence Says

No supplement does what Mounjaro or Wegovy do, and nothing sold as a GLP-1 booster comes close. The medicines are engineered hormones that keep their receptors stimulated all week; in one manufacturer-funded trial of 30 adults, semaglutide cut food intake by about a quarter without dietary instruction.¹ The supplements marketed alongside them contain berberine, chromium, soluble fibre, protein, bitter plant extracts or a blend, and the best of those produce small, real effects on blood sugar or fullness measured in grams and millimoles, not in stones. This page goes through the ingredients one by one, says what each has shown, and names the one honest use for the category.

• Berberine: modest improvements in blood sugar in people with type 2 diabetes; small average weight change; not an appetite medicine
• Chromium: authorised wording for normal macronutrient metabolism and the maintenance of normal blood glucose levels; a Cochrane review found a weight difference of about 1.1 kg, which its authors judged of debatable clinical relevance
• Soluble fibre and protein: genuine, modest effects on fullness, from food or from a plain protein or fibre product
• Bitter extracts and "GLP-1 activators": laboratory cell findings, almost no human evidence
• Honest use: protein and fibre to hit targets a small appetite cannot, not to replace or mimic the medicine

Sources checked on 29 October 2026.

What a GLP-1 supplement claims, and what the medicine does

Products in this category say they raise your body's own GLP-1, the gut hormone that signals fullness, or that they "support GLP-1" or do what the injections do. Some foods and nutrients do raise GLP-1 after a meal, briefly; which foods increase GLP-1 covers that evidence. Tirzepatide and semaglutide are not a bigger version of that. They are modified hormones that resist breakdown, so a single weekly injection keeps receptors in the gut and brain stimulated continuously at levels the body never produces on its own.^{1, 2} That is the difference between a nudge and a lever, and no capsule bridges it. This is one chapter of the Wellgard guide to living well on Mounjaro.

Berberine

The ingredient most often marketed with the medicine's name attached. It is a plant alkaloid with decades of trials, nearly all in people with type 2 diabetes, where pooled results show modest improvements in fasting glucose and HbA1c.³ On weight, the pooled trials show a small average reduction in weight and waist measurement, about 0.9 to 2 kg over several months.^{4, 5} It does raise GLP-1 secretion in laboratory cells through bitter taste receptors, which is where the marketing comes from.⁶ It is not an appetite medicine, the trials are short and the products are variable, and it interacts with several common medicines, so anyone on regular medication should check with a pharmacist first. Berberine is an interesting blood-sugar compound. It is not a GLP-1 medicine in a capsule, and the forms and formats berberine is sold in are compared on their own page. Berberine and gut health reports the trial rates of its gut side effects.

Chromium

Sold for blood sugar and cravings. A Cochrane review pooling 9 trials in 622 overweight or obese adults found chromium picolinate produced a weight difference of about 1.1 kg after 12 to 16 weeks, which the authors judged of debatable clinical relevance on low-quality evidence.⁷ Chromium contributes to normal macronutrient metabolism and to the maintenance of normal blood glucose levels, the authorised UK wording.¹¹ It has no authorised claim for appetite, and the Cochrane review measured weight, not appetite.

Soluble fibre and protein

These are the two ingredients in the category with evidence that holds up, and the reason is that they are food. Protein is the most filling nutrient per calorie and reliably raises GLP-1 and other fullness hormones after a meal.⁸ Soluble fibres, glucomannan and psyllium among them, slow stomach emptying and add bulk; pooled trials show modest effects on fullness and small effects on weight.⁹ Glucomannan has an authorised UK claim for weight loss, but only in the context of an energy-restricted diet at 3 g a day with plenty of water,¹¹ and that is precisely the diet the medicine already produces. A supplement that is mostly protein and fibre can be a reasonable way to hit targets a small appetite cannot; how much protein you need and constipation on Mounjaro explain where those targets sit. It does the same job as food, in a form a small appetite can manage.

Bitter extracts, "GLP-1 activators" and proprietary blends

Gentian, wormwood, hops extracts, olive leaf, cinnamon, green tea and a long tail of named "activators". The mechanism cited is real in a dish: bitter taste receptors in the gut release GLP-1 when stimulated, and plant compounds stimulate them.⁶ In people, the trials are small and short, and measure hormone levels for an hour or two rather than appetite or weight over months. Proprietary blends add a second problem: the dose of each ingredient is hidden, so even where one compound has evidence at a dose, you cannot tell whether the product contains it. A 2004 systematic review pooled 5 earlier reviews and 25 further trials of chromium, glucomannan, psyllium and several plant extracts and called the data encouraging but not definitive;¹⁰ glucomannan has since gained its authorised weight-loss claim,¹¹ and the bitter-extract products are newer than that review.

Why the comparison matters if you are on, or coming off, Mounjaro

On the medicine, a GLP-1 supplement adds nothing the receptors are not already getting, and berberine can interact with other medicines you take, so ask a pharmacist before adding it. Coming off the medicine is where most people meet berberine, and the honest comparison is two numbers: tirzepatide produced a 15 to 21% loss of body weight over 72 weeks in its main trial,² and berberine's pooled trials in people with type 2 diabetes produced about 0.9 to 2 kg and an HbA1c fall of about 0.6 percentage points.^{4, 5, 12} Berberine is a blood-sugar compound with that evidence behind it; it is not a replacement for the appetite effect of the medicine. What happens when you stop taking Mounjaro sets out what protects your results after stopping: protein, resistance training, fibre, routine and a conversation with your prescriber about maintenance.

What we don't know

• Berberine for appetite in people without diabetes. Almost unstudied.
• Whether any bitter extract changes food intake in humans over weeks. No adequate trial.
• Long-term safety of berberine at the doses sold; most trials ran three to six months.

Frequently asked questions

Do GLP-1 supplements work?

Not as a substitute for the medicine: none reproduces its effect on appetite or weight. The protein and fibre within them have modest, real effects on fullness, from food or from a plain protein or fibre product.^{8, 9}

Is berberine a substitute for Ozempic or Mounjaro?

No. In pooled trials it lowered HbA1c by about 0.6 percentage points and weight by about 0.9 to 2 kg in people with type 2 diabetes, against 15 to 21% for tirzepatide; it is not an appetite medicine and it interacts with common medicines.^{2, 4, 5, 12}

What is the best GLP-1 supplement in the UK?

There is no supplement that does what GLP-1 medicines do. If you want the fullness benefit of protein and fibre, a plain protein or fibre product does that job, and its label should say only what its ingredients are authorised to say.

Can I take GLP-1 supplements with Mounjaro?

They add nothing the medicine is not already doing, and berberine products can interact with other medicines. Ask a pharmacist before adding anything.

Sources

1. Blundell J, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 2017. Randomised crossover trial, 30 adults, 12 weeks; manufacturer-funded. PubMed 28266779.
2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022. Randomised trial (SURMOUNT-1), 2,539 adults, 72 weeks; manufacturer-funded. PubMed 35658024.
3. Guo J, et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxidative Medicine and Cellular Longevity, 2021. Pooled analysis of 46 randomised trials in people with type 2 diabetes; HbA1c 0.73 percentage points lower; no conflicts declared. PubMed 34956436.
4. Asbaghi O, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: a systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 2020. Pooled analysis of 12 randomised trials; weight 2.07 kg lower; no conflicts declared. PubMed 32690176.
5. Elahi Vahed I, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. International Journal of Obesity, 2026. Pooled analysis of 23 trials; weight 0.88 kg lower; no competing interests declared. PubMed 41310257.
6. Yu Y, et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochemical Pharmacology, 2015. Laboratory study in a human gut cell line; funding not stated on PubMed. PubMed 26206195.
7. Tian H, et al. Chromium picolinate supplementation for overweight or obese adults. Cochrane Database of Systematic Reviews, 2013. Cochrane review, 9 randomised trials, 622 adults, up to 24 weeks, low-quality evidence; no conflicts known. PubMed 24293292.
8. Kohanmoo A, et al. Effect of short- and long-term protein consumption on appetite and appetite-regulating gastrointestinal hormones, a systematic review and meta-analysis of randomized controlled trials. Physiology and Behavior, 2020. Pooled analysis of 49 acute and 19 longer-term trials; funding not stated on PubMed. PubMed 32768415.
9. Akhlaghi M. The role of dietary fibers in regulating appetite, an overview of mechanisms and weight consequences. Critical Reviews in Food Science and Nutrition, 2024. Narrative review; funding not stated on PubMed. PubMed 36193993.
10. Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. American Journal of Clinical Nutrition, 2004. Systematic review of 5 earlier reviews and 25 trials; funding not stated on PubMed. PubMed 15051593.
11. Department of Health and Social Care. Great Britain nutrition and health claims (NHC) register, last updated 19 May 2026. gov.uk.
12. Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Frontiers in Pharmacology, 2022. Pooled analysis of 37 randomised trials, 3,048 adults with type 2 diabetes; HbA1c 0.63 percentage points lower; no conflicts declared. PubMed 36467075.

Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.

This article is general information, not medical advice. Berberine and other supplements can interact with prescription medicines; speak to a pharmacist before adding one, and never stop or replace a prescribed medicine on the strength of a supplement claim.